Metlife Inc
(MET-NYSE)
INSURANCE - Life Insurance
Stock report updated on 01/20/2012
- MET is one of this month's top performers with a return of 20.5%, beating 90 percent of stocks in the S&P-100.
- The price of this high-beta stock is expected to increase by 1.74% for every 1% increase in the S&P-500.
- Volatility is forecast to rise over the next month.
- With RSI > 70, MET is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| Closing price: |
$36.35 |
| Support price level: |
$35.14 |
| Resistance price level: |
N/A |
| Relative strength index (14-day RSI): |
80.2 |
| Beta: |
1.74 |
52-Week Range
| Low |
High |
Price as % of Range |
| $26.60 |
$48.63 |
51.8% |
Moving Averages
| 200 day |
50 day |
20 day |
10 day |
| $36.46 |
$31.90 |
$33.23 |
$35.01 |
Volatility (annualized std. dev.)
Historical
(5 year) |
Last month |
Current estimate |
Next month forecast |
| 65.7% |
50.9% |
31.2% |
52.7% |
Value at Risk
There is an estimated 5% probability that the stock price of Metlife Inc will fall by more than:
- 8.5% in the next week.
- 29.8% in the next month.
- 88.4% in the next year.
Company News for Metlife Inc
Google Finance |
MSN Money |
Reuters
Reports for Other Stocks
